DIGNITY Trial for RCW Breast Cancer

77 views

Uploaded on October 05, 2009 by MultiVu

Celsion Corporation (NASDAQ:CLSN) announced today initiation of a nationwide enrollment program in its pivotal Phase I/II DIGNITY clinical trial evaluating the use of ThermoDox® in combination with hyperthermia for the treatment of Recurrent Chest Wall (RCW) Breast Cancer. In early studies, conducted at Duke University Medical Center, investigators report that ThermoDox® has demonstrated significant promise in treating this highly aggressive disease.

To view Multimedia News Release, go to
http://www2.prnewswire.com/mnr/celsion/39944/

Tags:
Celsion, ThermoDox, DIGNITY, Clinical, Trial, Recurrent, Chest, Wall, RCW, Breast, Cancer, Treatment, News & Events
Comments on DIGNITY Trial for RCW Breast Cancer

RECOMMENDED CHANNELS